HPV Prevalence in pregnant women
DOI:
https://doi.org/10.56294/piii2023170Keywords:
HPV, pregnant women, Pap Test, Colposcopy, risk factors in pregnant womenAbstract
Background: Human Papilloma virus (HPV) is very common virus in the global population. It is mainly transmitted through sexual contact and can also be transmitted from mother to child during childbirth. There are more than 100 different types of HPV, and most infected individuals do not present symptoms. However, some types of HPV can cause genital warts, while others can lead to change in cervical cells, increasing the risk of cervical cancer development. The best way to prevent HPV infection is through vaccination, along with use of condoms during secual intercourse. It Is essential for women to undergo regular screenings such as Pap test and colposcopy, as they help in the early detection of any cellular changes in the cervix and receiving appropriate treatment if necessary.. Material and methods: This is a retrospective observational study conducted by analyzing the medical records of pregnant women who gave birth in the year 2017 at The Ana Goitia maternal and Child Specialized Hospital. Results: From this research work, we arrived at the result that 24,2%(n=78) of pregnant women underwent the papanicolaou test. Amog them, 71%(n=55) tested negative, 27%(n=21) were classified as PAP class 2 and 2%(n=2) positive for HPV. Conclusion: After analyzing de medical records of the mentioned hospital, it was evident that very few individuals had undergone the papanicolaou test. As consequence, a low number of pregnant women were found to have any abnormalities in the test o tested positive for HPV. This made in challenging to determine the prevalence of this disease In the study population
References
Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol. maio de 2010;117(2):S5–10.
Cirino ES, Barbosa MCL. Incidência do Papiloma Vírus Humano – HPV em gestantes: uma revisão integrativa / Incidence of Human Papilloma Virus - HPV in pregnant women: an integrative review. Braz J Health Rev. 22 de junho de 2020;3(3):6727–36.
Jordá GB, Ramos JM, Mosmann J, Lopez ML, Wegert A. Prevalence of human papillomavirus and associated risk factors in women affiliated with. Rev Chil Infectol. :6.
Chen Y, Dong J, Chu B, Zhang X, Ru X, Chen Y, et al. Characteristics and Related Factors of High-Risk Human Papillomavirus Infection in Pregnant Women. Med Sci Monit Int Med J Exp Clin Res. 12 de julho de 2021;27:e929100-1-e929100-10.
Juliana NCA, Juma MH, Heijmans R, Ouburg S, Ali SM, Chauhan AS, et al. Detection of high-risk human papillomavirus (HPV) by the novel AmpFire isothermal HPV assay among pregnant women in Pemba Island, Tanzania. Pan Afr Med J. 27 de outubro de 2020;37:183.
Salcedo MMBP, Damin APS, Agnes G, Pessini SA, Beitune PE, Alexandre COP, et al. Prevalence of human papillomavirus infection in pregnant versus non-pregnant women in Brazil. Arch Gynecol Obstet. dezembro de 2015;292(6):1273–8.
Entiauspe LG, Silveira M, Nunes EM, Basgalupp SP, Stauffert D, Dellagostin OA, et al. High incidence of oncogenic HPV genotypes found in women from Southern Brazil. Braz J Microbiol. 29 de agosto de 2014;45(2):689–94.
de Souza HD, Waissman AL, Diório GRM, Peres SV, Francisco RPV, Galletta MAK. Prevalence of oncogenic human papillomavirus in pregnant adolescents, association with colpocytological changes, risk factors and obstetric outcomes. Clinics. 31 de outubro de 2022;77:100127.
Jenkins TM, Shojaei H, Song SJ, Schwartz LE. Role of Ancillary Techniques in Cervical Biopsy and Endocervical Curettage Specimens as Follow-Up to Papanicolaou Test Results Indicating a Diagnosis of Atypical Squamous Cells, Cannot Exclude HighGrade Squamous Intraepithelial Lesion, or HighGrade Squamous Intraepithelial Lesion. Acta Cytol. 2020;64(1–2):155–65.
Argentina.gob.ar [Internet]. Argentina.gob.ar. [citado 31 de maio de 2023]. Disponível em: https://www.argentina.gob.ar/
de Cerqueira JC, de Lima Moreira JP, dos Santos Brito A, Raggio Luiz e R. Indicador preventivo de saúde da mulher: proposta combinada de mamografia e Papanicolaou. Rev Panam Salud Pública. 21 de julho de 2017;41:e99.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Isabel Silveira Pinto e Grossi, Estela Mercedes Acosta (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
